IE
STIM icon

Israel Englander’s Neuronetics STIM Stock Holding History

Israel Englander’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,800
Closed -$137K – 7464
2021
Q4 		$137K Buy
+30,800
New +$151K ﹤0.01% 6117

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Israel Englander's STIM Position: Q2 2026 in Review

Israel Englander opened a new position in Neuronetics (STIM) in Q2 2026: 199,450 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #5189 among its holdings. This is a return to the name: Israel Englander previously reported a position in STIM as recently as Q4 2025.

Israel Englander first reported a position in STIM in Q2 2018 and has held it in 24 quarters since. The position peaked at $3.9M in Q1 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Israel Englander held 199,450 shares of Neuronetics worth $259K as of Q2 2026.
  • Neuronetics was a new Israel Englander position in Q2 2026.
  • Neuronetics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5189 holding.
  • Israel Englander first reported a position in Neuronetics in Q2 2018 and has held it in 24 quarters since.
  • Israel Englander's Neuronetics position peaked at $3.9M in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.